Discover how combined aortic stenosis treatment with valve replacement and drug therapy significantly improves survival in ...

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...

The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

In a major medical breakthrough for Rajasthan, doctors at Eternal Hospital, Jaipur, have successfully replaced the tricuspid ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

In a first for Nagpur, a remarkable milestone in cardiac care was achieved as three transcatheter aortic valve implantation ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...